# Therapeutic Strategy and the Role of Mesenchymal Stromal Cells for ABO Incompatible Liver Transplantation

> **NCT02706132** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 15 (estimated)

## Conditions studied

- Liver Transplantation

## Interventions

- **BIOLOGICAL:** Mesenchymal Stem Cells(MSCs)

## Key facts

- **NCT ID:** NCT02706132
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2016-12
- **Final completion:** 2017-03
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2016-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02706132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02706132, "Therapeutic Strategy and the Role of Mesenchymal Stromal Cells for ABO Incompatible Liver Transplantation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02706132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*